Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.5 USD | -1.92% | -5.68% | -6.44% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.44% | 212M | |
+10.58% | 115B | |
+12.74% | 106B | |
-4.61% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.05% | 17.56B | |
-39.36% | 17.32B | |
+6.81% | 14.03B | |
+32.64% | 12.13B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- INmune Bio Alzheimer's Treatment Remains on Clinical Hold After FDA Requests Information; Shares Slump After Hours